Literature DB >> 17911380

Alternative promoter usage and alternative splicing contribute to mRNA heterogeneity of mouse monocarboxylate transporter 2.

Shelley X L Zhang1, Tina R Searcy, Yiman Wu, David Gozal, Yang Wang.   

Abstract

Expression patterns of monocarboxylate transporter 2 (MCT2) display mRNA diversity in a tissue-specific fashion. We cloned and characterized multiple mct2 5'-cDNA ends from the mouse and determined the structural organization of the mct2 gene. We found that transcription of this gene was initiated from five independent genomic regions that spanned >80 kb on chromosome 10, resulting in five unique exon 1 variants (exons 1a, 1b, 1c, 1d, and 1e) that were then spliced to the common exon 2. Alternative splicing of four internal exons (exons AS1, AS2, AS3, and exon 3) greatly increased the complexity of mRNA diversity. While exon 1c was relatively commonly used for transcription initiation in various tissues, other exon 1 variants were used in a tissue-specific fashion, especially exons 1b and 1d that were used exclusively for testis-specific expression. Sequence analysis of 5'-flanking regions upstream of exons 1a, 1b, and 1c revealed the presence of numerous potential binding sites for ubiquitous transcription factors in all three regions and for transcription factors implicated in testis-specific or hypoxia-induced gene expression in the 1b region. Transient transfection assays demonstrated that each of the three regions contained a functional promoter and that the in vitro, cell type-specific activities of these promoters were consistent with the tissue-specific expression pattern of the mct2 gene in vivo. These results indicate that tissue-specific expression of the mct2 gene is controlled by multiple alternative promoters and that both alternative promoter usage and alternative splicing contribute to the remarkable mRNA diversity of the gene.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17911380     DOI: 10.1152/physiolgenomics.00192.2007

Source DB:  PubMed          Journal:  Physiol Genomics        ISSN: 1094-8341            Impact factor:   3.107


  7 in total

1.  Monocarboxylate transporter 2 and stroke severity in a rodent model of sleep apnea.

Authors:  Yang Wang; Shang Z Guo; Arend Bonen; Richard C Li; Leila Kheirandish-Gozal; Shelley X L Zhang; Kenneth R Brittian; David Gozal
Journal:  J Neurosci       Date:  2011-07-13       Impact factor: 6.167

Review 2.  Overview of the proton-coupled MCT (SLC16A) family of transporters: characterization, function and role in the transport of the drug of abuse gamma-hydroxybutyric acid.

Authors:  Marilyn E Morris; Melanie A Felmlee
Journal:  AAPS J       Date:  2008-06-04       Impact factor: 4.009

3.  Type I epithelial cells are the main target of whole-body hypoxic preconditioning in the lung.

Authors:  Shelley X L Zhang; James J Miller; Donna Beer Stolz; Laura D Serpero; Wei Zhao; David Gozal; Yang Wang
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-05       Impact factor: 6.914

4.  Dynamic usage of alternative splicing exons during mouse retina development.

Authors:  Jun Wan; Tomohiro Masuda; Laszlo Hackler; Kieron M Torres; Shannath L Merbs; Donald J Zack; Jiang Qian
Journal:  Nucleic Acids Res       Date:  2011-06-30       Impact factor: 16.971

5.  Identification of a novel human LAP1 isoform that is regulated by protein phosphorylation.

Authors:  Mariana Santos; Sara C Domingues; Patrícia Costa; Thorsten Muller; Sara Galozzi; Katrin Marcus; Edgar F da Cruz e Silva; Odete A da Cruz e Silva; Sandra Rebelo
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

6.  pH, Lactate, and Hypoxia: Reciprocity in Regulating High-Affinity Monocarboxylate Transporter Expression in Glioblastoma.

Authors:  James P Caruso; Brandon J Koch; Philip D Benson; Elsa Varughese; Michael D Monterey; Amy E Lee; Ajal M Dave; Sam Kiousis; Andrew E Sloan; Saroj P Mathupala
Journal:  Neoplasia       Date:  2017-01-13       Impact factor: 5.715

Review 7.  Getting started: altering promoter choice as a mechanism for cell type differentiation.

Authors:  Mukulika Ray; Erica Larschan
Journal:  Genes Dev       Date:  2020-05-01       Impact factor: 11.361

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.